AEZS


AEterna Zentaris Inc. (USA) (AEZS) CEO’s Departure Raises Questions

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday’s trading session, following the news that CEO David Dodd is stepping …

Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA) (AEZS), Vertex Pharmaceuticals Incorporated (VRTX)

Many investors hope to win big on biotech stocks as shares can skyrocket when there is good news. Maxim analysts explain why there …

AEterna Zentaris Inc. (USA) (AEZS) Announces NDA Filing Acceptance By FDA For Macrilen; Shares Rise

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has been notified by the U.

AEterna Zentaris Inc. (USA) (AEZS) Resubmits New Drug Application for Macrilen; Shares Rise

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are up nearly 8% in pre-market trading Friday, after the drug maker announced that it has resubmitted …

Analysts Shine Light on Merrimack Pharmaceuticals Inc (MACK) and AEterna Zentaris Inc. (USA) (AEZS)

Merrimack Pharmaceuticals In a research report sent to investors Wednesday, Cowen’s top analyst Eric Schmidt reiterated a Market Perform rating on shares of Merrimack …

Aeterna Zentaris Inc (USA) (AEZS) Announces Q1:17 Results

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the first quarter ended March 31, 2017.

Maxim Slashes Price Target on AEterna Zentaris Inc. (USA) (AEZS) Following Disappointing Clinical Results in Endometrial Cancer

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are collapsing 60% after underwhelming investors who had been optimistic about the company’s ZoptEC Phase 3 clinical study.

Why AEterna Zentaris Inc. (USA) (AEZS) Shares Collapsed Today

Friday turned out to be a nightmare for shareholders of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the drug maker announced that its ZoptEC Phase …

AEterna Zentaris Inc. (USA) Announces Replacement At the Market Issuance Program

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has entered into a new At Market Issuance Sales Agreement, dated April 27, 2017, with …

AEterna Zentaris Inc. (USA) (AEZS) Macrilen Is Back, Cheers Maxim

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are rising almost 8% today on the heels of indicating it intends to file a new drug …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts